Israel - hebraico - Ministry of Health

bayer israel ltd - clodronic acid disodium 60 mg/ml - concentrate for solution for infusion - clodronic acid - treatment of hypercalcemia due to malignancy and treatment of osteolytic bone metastatses in connection with conventional cancer therapy.

Israel - hebraico - Ministry of Health

bayer israel ltd - clodronic acid disodium 800 mg - film coated tablets - clodronic acid - treatment of hypercalcemia due to malignancy. palliative treatment of osteolysis due to malignancy.

Israel - hebraico - Ministry of Health

merck sharp & dohme israel ltd - alendronic acid as sodium 10 mg - tablets - alendronic acid - treatment of osteoporosis in postmenopausal women: fosalan is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures including those of the hip and spine ( vertebral compression fractures). for the treatment of osteoporosis in men. prevention and treatment of glucocorticoid-induced osteoporosis in postmenopausal women not receiving estrogen.

Israel - hebraico - Ministry of Health

teva pharmaceutical indust.ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.

Israel - hebraico - Ministry of Health

bioavenir ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - alendronate bioavenir is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures) .

Israel - hebraico - Ministry of Health

abic marketing ltd - risedronic acid sodium 75 mg - tablets - risedronic acid - treatment of osteoporosis in postmenopausal women at increased risk of fractures.prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.

Israel - hebraico - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - powder for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

Israel - hebraico - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

Israel - hebraico - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

Israel - hebraico - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.